Rockefeller Capital Management L.P. Trims Stock Position in Aflac Incorporated (NYSE:AFL)

Rockefeller Capital Management L.P. cut its holdings in Aflac Incorporated (NYSE:AFL - Free Report) by 7.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 384,014 shares of the financial services provider's stock after selling 29,266 shares during the period. Rockefeller Capital Management L.P. owned 0.07% of Aflac worth $39,719,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in shares of Aflac by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider's stock worth $5,310,640,000 after purchasing an additional 653,275 shares during the period. Geode Capital Management LLC lifted its position in Aflac by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 12,465,433 shares of the financial services provider's stock valued at $1,286,042,000 after buying an additional 288,482 shares during the last quarter. Norges Bank purchased a new position in Aflac during the fourth quarter worth about $349,699,000. Charles Schwab Investment Management Inc. increased its position in shares of Aflac by 1.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,226,681 shares of the financial services provider's stock valued at $333,768,000 after acquiring an additional 47,119 shares during the last quarter. Finally, Amundi raised its stake in shares of Aflac by 81.1% in the 4th quarter. Amundi now owns 2,753,513 shares of the financial services provider's stock valued at $285,181,000 after acquiring an additional 1,232,683 shares during the period. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the sale, the director now directly owns 25,393 shares of the company's stock, valued at $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of the company's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the transaction, the director now owns 49,962 shares of the company's stock, valued at $5,360,422.98. This represents a 37.36 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.90% of the company's stock.

Aflac Trading Up 2.1 %

NYSE AFL opened at $106.84 on Friday. Aflac Incorporated has a 52 week low of $79.31 and a 52 week high of $115.50. The firm has a 50 day moving average of $106.34 and a two-hundred day moving average of $107.42. The stock has a market capitalization of $58.31 billion, a PE ratio of 11.13, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.

Remove Ads

Aflac (NYSE:AFL - Get Free Report) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts' consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. As a group, research analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AFL has been the subject of a number of research analyst reports. UBS Group increased their price objective on shares of Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 2nd. Piper Sandler raised their price target on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. StockNews.com upgraded Aflac from a "sell" rating to a "hold" rating in a report on Friday, February 14th. Keefe, Bruyette & Woods decreased their target price on Aflac from $107.00 to $104.00 and set a "market perform" rating on the stock in a research note on Wednesday, February 12th. Finally, BMO Capital Markets began coverage on Aflac in a research report on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 target price for the company. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $103.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.